Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$16.76 Mil
% of Total Estimate Gain
29.72%

RA CAPITAL MANAGEMENT, L.P.'s Praxis Precision Medicines Inc Holding Summary

As of 2025-03-31, RA CAPITAL MANAGEMENT, L.P. held - shares of Praxis Precision Medicines Inc(PRAX), totaling N/A. This investment constitutes 0% of their stock portfolio, and RA CAPITAL MANAGEMENT, L.P. now holds 0% of the outstanding Praxis Precision Medicines Inc(PRAX) stock.

The initial trade took place in 2024Q1. And since then RA CAPITAL MANAGEMENT, L.P. has made 2 purchases of PRAX, at an average price of $45.65, for a total of 1.24 Mil shares. In addition, there have been 2 sales at an average price of $59.22 for 1.24 Mil shares. Based on historical transaction data and PRAX's current price of $53.85, RA CAPITAL MANAGEMENT, L.P.'s estimated gain on his PRAX holdings is $16.76 Mil, reflecting a 29.72% gain to date.

RA CAPITAL MANAGEMENT, L.P. PRAX ($53.85) Holding Chart

RA CAPITAL MANAGEMENT, L.P. PRAX ($53.85) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1